Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Economic Evaluation of Vancomycin TDM Methods
NCT04297176Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Jan 2020
- Primary completion
- May 2021
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vancomycin in bacterial infection (2 arms), sponsored by Hamad Medical Corporation. Primary endpoints: Therapeutic success (Composite of clinical cure and/or microbiologic cure) at 1 month and Cost-benefit analysis at 1 month. Started Jan 2020; status: completed.
02
Drugs
vancomycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04297176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297176.